跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIRTAZAPINA AUROVITAS SPAIN 15 MG COMPRIMIDOS BUCODISPERSABLES EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MIRTAZAPINA AUROVITAS SPAIN 15 MG COMPRIMIDOS BUCODISPERSABLES EFG
Approved
STANDARD
MIRTAZAPINA AUROVITAS SPAIN 15 MG COMPRIMIDOS BUCODISPERSABLES EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 29, 2020
Approval ID
8af74a5ae3be1d2d
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
8af74a5ae3be1d2d
Drug Cima Aemps Name
MIRTAZAPINA AUROVITAS SPAIN 15 MG COMPRIMIDOS BUCODISPERSABLES EFG
Register Number
85207
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2020-06-29
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
15 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
MIRTAZAPINA
15 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 29, 2020
Approval ID
8af74a5ae3be1d2d
Type
Standard
Back to CIMA-AEMPS Approvals